Similar Papers

Paper Title
Journal
Date
Author
A report released by the Canadian Diabetes Association (CDA) recommends that Canada's drug review process be enhanced to ensure wider drug access.
-
PharmacoEconomics & Outcomes News | VOL. 668
--
01 Dec 2012
Can the Present Canadian Health Care System Provide Evidence-Based Pharmaceutical Care? Consideration of Two Important Cardiovascular Clinical Contexts.
Morgane Laverdure ... Derek Y F So
The Canadian journal of cardiology | VOL. -
Morgane Laverdure, et. al.Morgane Laverdure ... Derek Y F So
01 Dec 2024
The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada
Jean H. E. Yong ... Jaclyn Beca
PharmacoEconomics | VOL. 31
Jean H. E. Yong, et. al.Jean H. E. Yong ... Jaclyn Beca
16 Jan 2013
The drug regulatory and review process in Guyana.
Rex B Woo‐Ming
Journal of clinical pharmacology | VOL. 33
Rex B Woo‐MingRex B Woo‐Ming
01 Jan 1992
View more papers

More From: PharmacoEconomics & Outcomes News

Paper Title
Journal
Date
Author
SAPIEN 3 TAVI cost effective vs surgical valve replacement for severe aortic stenosis in France
-
PharmacoEconomics & Outcomes News | VOL. 893
--
01 Dec 2021
A Fond Farewell from PharmacoEconomics & Outcomes News
-
PharmacoEconomics & Outcomes News | VOL. 893
--
01 Dec 2021
Radiation therapy cost-effective option for low-risk localised prostate cancer in Australia
-
PharmacoEconomics & Outcomes News | VOL. 893
--
01 Dec 2021
Indacaterol/glycopyrronium/mometasone cost effective in Canada
-
PharmacoEconomics & Outcomes News | VOL. 893
--
01 Dec 2021
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.